Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.4246
+0.0166 (4.07%)
At close: Oct 29, 2026
Vaxart Market Cap
Vaxart has a market cap or net worth of $103.26 million as of October 29, 2026. It is the 24,833rd most valuable company in the world and the 4,073rd biggest in the United States. Its market cap has increased by 29.14% in one year.
Market Cap
103.26M
Enterprise Value
51.82M
Revenue
243.07M
Global Rank
Country Rank
#4,073 United States
PE Ratio
2.62
ChartMarket Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from 60.35M to 103.26M, an increase of 71.11%. That is a compound annual growth rate of 6.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 103.26M | 24.22% |
| Dec 31, 2025 | 83.13M | -44.81% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 319.91M |
| Northwest Biotherapeutics | 275.46M |
| Glorywin Entertainment Group | 234.77M |
| HST Global | 209.33M |
| BetterLife Pharma | 101.23M |
| ProText Mobility | 74.73M |
| Nuo Therapeutics | 62.96M |
| Sangamo Therapeutics | 48.93M |